deCODE genetics (DCGN) Suspended From NASDAQ Trading; Probable Move to 'Pink Sheets'
deCODE genetics, Inc. (Nasdaq: DCGN) has received notice from the Nasdaq Stock Market that the company's common stock will be suspended from the Nasdaq Stock Market as of the open of business on January 6, 2010 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove deCODE's common stock from listing on Nasdaq.
Following this action, it is possible that deCODE's common stock will be traded on the inter-dealer quotation service known as the "Pink Sheets." However this is not certain, as it would require a market maker to quote the stock, and there is no guarantee that any market maker will do so. In addition, so long as deCODE is not current in its reporting obligations under the Securities Exchange Act of 1934, any such quotation will be subject to additional restrictions.
[SM]
Following this action, it is possible that deCODE's common stock will be traded on the inter-dealer quotation service known as the "Pink Sheets." However this is not certain, as it would require a market maker to quote the stock, and there is no guarantee that any market maker will do so. In addition, so long as deCODE is not current in its reporting obligations under the Securities Exchange Act of 1934, any such quotation will be subject to additional restrictions.
[SM]
You May Also Be Interested In
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
- BofA (BAC), Barclays (BCS) to Sell Remaining Archstone Interest in $1.58B Deal to Lehman Bros.
- PDI, Inc. (PDII) Enters New $57M PCP Targeting Contract
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
